淋巴激素释放激素 (GnRH) 激活剂在接受干细胞移植的患者中不保护卵巢功能
1Reproductive Endocrinology and Infertility, National Institutes of Health, Bethesda, USA.
Cureus
|May 17, 2024
概括
淋巴激素释放激素激动剂 (GnRH-a) 在接受血造干细胞移植 (HSCT) 的女性中没有预防原发性卵巢缺陷 (POI). 对于这些面临性腺毒性治疗的患者来说,保持生育能力仍然至关重要.
科学领域:
- 生殖内分泌学 生殖内分泌学
- 在瘤学瘤学.
- 血液学 血液学 血液学
背景情况:
- 对于接受恶性瘤或慢性疾病的淋巴毒性治疗的患者来说,保持生育能力至关重要.
- 淋巴激素释放激素激动剂 (GnRH-a) 正在探索抑制卵巢功能和减轻化疗对毛囊池的影响.
- 造血干细胞移植 (HSCT) 涉及具有显著淋巴毒性潜力的调节方案,风险为原发性卵巢缺陷 (POI).
研究的目的:
- 研究GnRH-a的乐普罗立德在接受HSCT的患者中预防POI的疗效.
- 测试GnRH-a在遵循HSCT调节方案后对保持卵巢功能无效的假设.
主要方法:
- 一项队列研究评估了29名在国家卫生研究院 (NIH) 在HSCT之前接受生育保护的患者.
- 毛囊刺激激素 (FSH) 水平在化疗前和后被评估.
- 患者被分为对照组 (没有GnRH-a) 和治疗组 (在化疗前接受GnRH-a).
主要成果:
- 80%的对照组在化疗后经历了更年期FSH水平.
- 使用GnRH-a的治疗组中有91%的患者在化疗后也经历了更年期FSH水平.
- 群体之间的POI率差异在统计学上并不显著 (p=0.33).
结论:
- 该研究证实了GnRH-a在接受HSCT调节方案的患者中降低POI风险是无效的假设.
- 卵巢功能受到HSCT条件的显著影响,无论GnRH-a的使用情况如何.
- 需要进一步的策略来改善HSCT患者的生育保护结果.
相关概念视频
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Oogenesis
63.7K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.7K
Bone Marrow Sampling and Transplants
325
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
325
Tissue Transplantation
360
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
360


